In 2007, the American Heart Association outlined essential features of a surveillance system to support prevention and management of cardiovascular disease (CVD) and stroke.1 These recommendations were made to primarily inform, support, and expand ongoing federal surveillance. Although this work may be assumed to be the role of governments, should anyone else be responsible for such surveillance? Like any other robust system, ideal surveillance for CVD would presumably include a check-and-balance mechanism, so independent monitoring should be welcome.
Huffman MD. Maturing Methods for Cardiovascular Disease and Stroke Surveillance in the United States. JAMA Cardiol. 2018;3(5):390. doi:10.1001/jamacardio.2018.0812
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: